214 related articles for article (PubMed ID: 19213760)
1. Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.
Sicard P; Jacquet S; Kobayashi KS; Flavell RA; Marber MS
Cardiovasc Res; 2009 Jul; 83(2):277-84. PubMed ID: 19213760
[TBL] [Abstract][Full Text] [Related]
2. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide.
Windheim M; Lang C; Peggie M; Plater LA; Cohen P
Biochem J; 2007 Jun; 404(2):179-90. PubMed ID: 17348859
[TBL] [Abstract][Full Text] [Related]
4. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
5. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
6. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
Morrison A; Yan X; Tong C; Li J
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Zhong B; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
[TBL] [Abstract][Full Text] [Related]
8. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
9. The role of RIP2 in p38 MAPK activation in the stressed heart.
Jacquet S; Nishino Y; Kumphune S; Sicard P; Clark JE; Kobayashi KS; Flavell RA; Eickhoff J; Cotten M; Marber MS
J Biol Chem; 2008 May; 283(18):11964-71. PubMed ID: 18310079
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
11. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
[TBL] [Abstract][Full Text] [Related]
12. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.
Moss NC; Stansfield WE; Willis MS; Tang RH; Selzman CH
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2248-53. PubMed ID: 17675566
[TBL] [Abstract][Full Text] [Related]
13. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
14. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
[TBL] [Abstract][Full Text] [Related]
15. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
Xie H; Zhang J; Zhu J; Liu LX; Rebecchi M; Hu SM; Wang C
Acta Pharmacol Sin; 2014 Dec; 35(12):1504-13. PubMed ID: 25345742
[TBL] [Abstract][Full Text] [Related]
17. Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.
Khaliulin I; Parker JE; Halestrap AP
Cardiovasc Res; 2010 Nov; 88(2):324-33. PubMed ID: 20558443
[TBL] [Abstract][Full Text] [Related]
18. The world of inhibitory kappaB.
Harken AH
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2624-5. PubMed ID: 17827258
[No Abstract] [Full Text] [Related]
19. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
